Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03310125 · ClinicalTrials.gov registry record · Phase 3
Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)
A Phase 3 study, sponsored by Population Health Research Institute.
- Completed
- Registry status
- Phase 3
- Development phase
- 3,209
- Enrollment target
NCT03310125 is a Phase 3 study that has completed, run by Population Health Research Institute. The registered enrollment target is 3,209 participants.
The verdict
NCT03310125, a Phase 3 study, has completed, sponsored by Population Health Research Institute.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 3,209 participants
- Enrollment target
Study Summary
The prevention of perioperative atrial fibrillation (AF) and myocardial injury after non-cardiac surgery (MINS) has the potential to reduce mortality, stroke, and hospital stays in patients undergoing major thoracic surgery. Data from cardiac surgery patients suggest that prevention of perioperative atrial fibrillation using an anti-inflammatory agent, such as colchicine, is feasible. The COP-AF trial will assess whether the administration of oral colchicine will reduce the incidence of perioperative atrial fibrillation and myocardial injury after non-cardiac surgery in patients undergoing major thoracic surgery.
Interventions
- DRUG Placebo
- DRUG Colchicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,209 participants |
| Start Date | 2018-02-14 |
| Est. Completion | 2023-07-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03310125
The ClinicalTrials.gov registry entry for NCT03310125 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 3,209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Population Health Research Institute, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03310125 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03310125 about?
NCT03310125 is a clinical study titled "Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF)". The prevention of perioperative atrial fibrillation (AF) and myocardial injury after non-cardiac surgery (MINS) has the potential to reduce mortality, stroke, and hospital stays in patients undergoing major thoracic surgery. Data from cardiac surgery patients suggest that prevention of perioperative...
What is the current status of trial NCT03310125?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 3,209 participants. The study started on 2018-02-14. Estimated completion is 2023-07-26.
What interventions are being tested in trial NCT03310125?
The interventions under investigation include: Placebo (DRUG), Colchicine (DRUG).
Who is sponsoring clinical trial NCT03310125?
This trial is sponsored by Population Health Research Institute, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.